Cytokine response during hyperoxia: Sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats

Citation
J. Ben-ari et al., Cytokine response during hyperoxia: Sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats, ISR MED ASS, 2(5), 2000, pp. 365-369
Citations number
25
Categorie Soggetti
General & Internal Medicine
Journal title
ISRAEL MEDICAL ASSOCIATION JOURNAL
ISSN journal
15651088 → ACNP
Volume
2
Issue
5
Year of publication
2000
Pages
365 - 369
Database
ISI
SICI code
1565-1088(200005)2:5<365:CRDHSP>2.0.ZU;2-W
Abstract
Background: Exposure of newborn animals to high concentrations of oxygen le ads to diffuse alveolar damage similar to that seen in bronchopulmonary dys plasia in human infants. Therefore, neonatal rats are a suitable practical model of hyperoxic lung damage in human infants. Objective: To determine the involvement of tumor necrosis factor-alpha and interleukin-6 in lung injury in neonatal rats exposed to 100% O-2 concentra tion. Methods: A randomized controlled study was designed in which litters of ter m Sprague-Dawley rat pups were assigned to experimental or control groups. The pups in the experimental group were placed in 100% O-2 from birth for 9 days, while the control pups were placed in room air. Twelve to 15 pups fr om each group were sacrificed on day 1, 3, 6, 9 and 13 after birth for bron choalveolar lavage collection and lung histologic study. The bronchoalveola r lavage fluid was assayed for TNF alpha and IL-6. Results: Newborn rats exposed to 100% O-2 for the first 9 days of life show ed severe pulmonary edema and hypercellularity on days 1 and 3, which then improved to nearly complete resolution on days 6 and 9. Pulmonary TNFa was produced early on O-2 exposure (day 3) and pulmonary IL-6 later (days 6 and 9). Conclusions: Hyperoxia induces sequential production of pulmonary TNFa and IL-6, which corresponds to the severity of the pathological findings and th e known inflammatory and anti-inflammatory role of these cytokines.